In recent years, a number of preclinical models have shown that cannabinoids may be highly effective at improving inflammation and, therefore, may be a potential treatment for inflammatory bowel diseases.
From 2017 to 2018, there were decreases in overdose death rates involving all opioids, prescription opioids, and heroin, while rates involving synthetic opioids increased.
Between 2000 and 2017, unintentional deaths and suicides related to opioid use have increased substantially, whereas overall deaths from have decreased.
Medication treatment with methadone and buprenorphine is associated with a significantly lower risk for overdose death for people with opioid use disorder compared with nonmedication treatment.
An enhanced recovery after surgery program complemented by a preemptive pain management program is associated with a decrease in opioid prescriptions at discharge following minimally invasive foregut surgery.
An ad campaign to inform people harmed by the prescription opioid OxyContin as to where they can file claims against maker Purdue Pharma was launched by the company as part of bankruptcy proceedings.
